The company's net loss ticked down after March labor cuts. The post Atai Life Sciences Remains Bullish on Mental Health Drug Trials Despite Cash Burn appeared...
Oregon, the first state to legalize psilocybin therapy services, continues to roll out the foundations of its new psychedelic medicine industry. Back in...
The article Mental Health Awareness: Depression was originally published on Microdose. May is Mental Health Awareness Month. And with the psychedelic...
The first three months of 2023 have been a whirlwind for the psychedelic industry– to say the least. Though it has been a particularly difficult quarter,...
KETARX is an injectable ketamine formulation to treat a symptom of Parkinson's. The post PharmaTher Asks FDA to Fast Track Ketamine Drug for Parkinson’s...
The article News You Might Have Missed: May 1st, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
We are in a mental health crisis, and we need new, more effective therapies fast. Psychedelic drugs such as psilocybin, DMT, LSD, MDMA, and ketamine have...
A new study by McGill University’s Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety.
A group of 10 Maryland Senators is co-sponsoring a new bill proposing to establish a state fund to provide military veterans suffering from post-traumatic...
A Hawaii legislative committee has unanimously approved a bill that proposes the establishment of a working group to study the therapeutic benefits of...